Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × lorlatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Non Small Cell Lung Cancer Metastatic 2 Neuroblastoma 2 Lung Neoplasms 2 Recurrence 1 Neoplasm Metastasis 1 NSCLC 1 Glioma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma 1 Astrocytoma 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡